Report Detail

Pharma & Healthcare Global Buprenorphine Hydrochloride Tablets Market Research Report 2021

  • RnM4314119
  • |
  • 01 May, 2021
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
0.5mg
2mg

Segment by Application
Analgesic
Opioid Antagonist

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Teva


1 Buprenorphine Hydrochloride Tablets Market Overview

  • 1.1 Product Overview and Scope of Buprenorphine Hydrochloride Tablets
  • 1.2 Buprenorphine Hydrochloride Tablets Segment by Type
    • 1.2.1 Global Buprenorphine Hydrochloride Tablets Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 0.5mg
    • 1.2.3 2mg
  • 1.3 Buprenorphine Hydrochloride Tablets Segment by Application
    • 1.3.1 Global Buprenorphine Hydrochloride Tablets Sales Comparison by Application: (2021-2027)
    • 1.3.2 Analgesic
    • 1.3.3 Opioid Antagonist
  • 1.4 Global Buprenorphine Hydrochloride Tablets Market Size Estimates and Forecasts
    • 1.4.1 Global Buprenorphine Hydrochloride Tablets Revenue 2016-2027
    • 1.4.2 Global Buprenorphine Hydrochloride Tablets Sales 2016-2027
    • 1.4.3 Buprenorphine Hydrochloride Tablets Market Size by Region: 2016 Versus 2021 Versus 2027

2 Buprenorphine Hydrochloride Tablets Market Competition by Manufacturers

  • 2.1 Global Buprenorphine Hydrochloride Tablets Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Buprenorphine Hydrochloride Tablets Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Buprenorphine Hydrochloride Tablets Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Buprenorphine Hydrochloride Tablets Manufacturing Sites, Area Served, Product Type
  • 2.5 Buprenorphine Hydrochloride Tablets Market Competitive Situation and Trends
    • 2.5.1 Buprenorphine Hydrochloride Tablets Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Buprenorphine Hydrochloride Tablets Players Market Share by Revenue
    • 2.5.3 Global Buprenorphine Hydrochloride Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Buprenorphine Hydrochloride Tablets Retrospective Market Scenario by Region

  • 3.1 Global Buprenorphine Hydrochloride Tablets Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Buprenorphine Hydrochloride Tablets Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
    • 3.3.1 North America Buprenorphine Hydrochloride Tablets Sales by Country
    • 3.3.2 North America Buprenorphine Hydrochloride Tablets Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
    • 3.4.1 Europe Buprenorphine Hydrochloride Tablets Sales by Country
    • 3.4.2 Europe Buprenorphine Hydrochloride Tablets Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Buprenorphine Hydrochloride Tablets Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Buprenorphine Hydrochloride Tablets Sales by Region
    • 3.5.2 Asia Pacific Buprenorphine Hydrochloride Tablets Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
    • 3.6.1 Latin America Buprenorphine Hydrochloride Tablets Sales by Country
    • 3.6.2 Latin America Buprenorphine Hydrochloride Tablets Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Buprenorphine Hydrochloride Tablets Sales by Country
    • 3.7.2 Middle East and Africa Buprenorphine Hydrochloride Tablets Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Buprenorphine Hydrochloride Tablets Historic Market Analysis by Type

  • 4.1 Global Buprenorphine Hydrochloride Tablets Sales Market Share by Type (2016-2021)
  • 4.2 Global Buprenorphine Hydrochloride Tablets Revenue Market Share by Type (2016-2021)
  • 4.3 Global Buprenorphine Hydrochloride Tablets Price by Type (2016-2021)

5 Global Buprenorphine Hydrochloride Tablets Historic Market Analysis by Application

  • 5.1 Global Buprenorphine Hydrochloride Tablets Sales Market Share by Application (2016-2021)
  • 5.2 Global Buprenorphine Hydrochloride Tablets Revenue Market Share by Application (2016-2021)
  • 5.3 Global Buprenorphine Hydrochloride Tablets Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Siegfried
    • 6.1.1 Siegfried Corporation Information
    • 6.1.2 Siegfried Description and Business Overview
    • 6.1.3 Siegfried Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Siegfried Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.1.5 Siegfried Recent Developments/Updates
  • 6.2 Sanofi
    • 6.2.1 Sanofi Corporation Information
    • 6.2.2 Sanofi Description and Business Overview
    • 6.2.3 Sanofi Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sanofi Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.2.5 Sanofi Recent Developments/Updates
  • 6.3 Johnson Matthey
    • 6.3.1 Johnson Matthey Corporation Information
    • 6.3.2 Johnson Matthey Description and Business Overview
    • 6.3.3 Johnson Matthey Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Johnson Matthey Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.3.5 Johnson Matthey Recent Developments/Updates
  • 6.4 Mallinckrodt
    • 6.4.1 Mallinckrodt Corporation Information
    • 6.4.2 Mallinckrodt Description and Business Overview
    • 6.4.3 Mallinckrodt Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Mallinckrodt Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.4.5 Mallinckrodt Recent Developments/Updates
  • 6.5 Noramco
    • 6.5.1 Noramco Corporation Information
    • 6.5.2 Noramco Description and Business Overview
    • 6.5.3 Noramco Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Noramco Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.5.5 Noramco Recent Developments/Updates
  • 6.6 Unichemlabs
    • 6.6.1 Unichemlabs Corporation Information
    • 6.6.2 Unichemlabs Description and Business Overview
    • 6.6.3 Unichemlabs Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Unichemlabs Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.6.5 Unichemlabs Recent Developments/Updates
  • 6.7 Arevipharma
    • 6.6.1 Arevipharma Corporation Information
    • 6.6.2 Arevipharma Description and Business Overview
    • 6.6.3 Arevipharma Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Arevipharma Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.7.5 Arevipharma Recent Developments/Updates
  • 6.8 Resonance-labs
    • 6.8.1 Resonance-labs Corporation Information
    • 6.8.2 Resonance-labs Description and Business Overview
    • 6.8.3 Resonance-labs Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Resonance-labs Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.8.5 Resonance-labs Recent Developments/Updates
  • 6.9 Sun Pharma
    • 6.9.1 Sun Pharma Corporation Information
    • 6.9.2 Sun Pharma Description and Business Overview
    • 6.9.3 Sun Pharma Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Sun Pharma Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.9.5 Sun Pharma Recent Developments/Updates
  • 6.10 Rusan Pharma
    • 6.10.1 Rusan Pharma Corporation Information
    • 6.10.2 Rusan Pharma Description and Business Overview
    • 6.10.3 Rusan Pharma Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Rusan Pharma Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.10.5 Rusan Pharma Recent Developments/Updates
  • 6.11 Micro Orgo Chem
    • 6.11.1 Micro Orgo Chem Corporation Information
    • 6.11.2 Micro Orgo Chem Buprenorphine Hydrochloride Tablets Description and Business Overview
    • 6.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Micro Orgo Chem Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.11.5 Micro Orgo Chem Recent Developments/Updates
  • 6.12 Faranshimi
    • 6.12.1 Faranshimi Corporation Information
    • 6.12.2 Faranshimi Buprenorphine Hydrochloride Tablets Description and Business Overview
    • 6.12.3 Faranshimi Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Faranshimi Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.12.5 Faranshimi Recent Developments/Updates
  • 6.13 Teva
    • 6.13.1 Teva Corporation Information
    • 6.13.2 Teva Buprenorphine Hydrochloride Tablets Description and Business Overview
    • 6.13.3 Teva Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Teva Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.13.5 Teva Recent Developments/Updates

7 Buprenorphine Hydrochloride Tablets Manufacturing Cost Analysis

  • 7.1 Buprenorphine Hydrochloride Tablets Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Buprenorphine Hydrochloride Tablets
  • 7.4 Buprenorphine Hydrochloride Tablets Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Buprenorphine Hydrochloride Tablets Distributors List
  • 8.3 Buprenorphine Hydrochloride Tablets Customers

9 Buprenorphine Hydrochloride Tablets Market Dynamics

  • 9.1 Buprenorphine Hydrochloride Tablets Industry Trends
  • 9.2 Buprenorphine Hydrochloride Tablets Growth Drivers
  • 9.3 Buprenorphine Hydrochloride Tablets Market Challenges
  • 9.4 Buprenorphine Hydrochloride Tablets Market Restraints

10 Global Market Forecast

  • 10.1 Buprenorphine Hydrochloride Tablets Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Buprenorphine Hydrochloride Tablets by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Buprenorphine Hydrochloride Tablets by Type (2022-2027)
  • 10.2 Buprenorphine Hydrochloride Tablets Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Buprenorphine Hydrochloride Tablets by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Buprenorphine Hydrochloride Tablets by Application (2022-2027)
  • 10.3 Buprenorphine Hydrochloride Tablets Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Buprenorphine Hydrochloride Tablets by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Buprenorphine Hydrochloride Tablets by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    Summary:
    Get latest Market Research Reports on Buprenorphine Hydrochloride Tablets. Industry analysis & Market Report on Buprenorphine Hydrochloride Tablets is a syndicated market report, published as Global Buprenorphine Hydrochloride Tablets Market Research Report 2021. It is complete Research Study and Industry Analysis of Buprenorphine Hydrochloride Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,349.00
    3,523.50
    4,698.00
    2,723.10
    4,084.65
    5,446.20
    448,804.00
    673,206.00
    897,608.00
    241,860.00
    362,790.00
    483,720.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report